CAR-Immunotherapy TRIALS

CAR-Immunotherapy package has 22 parameters for all trials registered internationally through 30 June 2018, including updates on their status. Cumulatively, 537 CAR-Immunotherapy trials have been registered worldwide. Purchasers will receive FREE UPDATES of new CAR-Immunotherapy trials twice a year for the next 3 years after purchase date.

• Trial Data
  • Registration Year
  • Trial ID with link to trial on-line
  • Country
  • Phase
  • Status (updated as of end of June 2018)
• Patient Data
  • Indication
  • Patient Age Groups
  • Target Enrollment
• Cell Data
  • CAR Target
  • Cell Type
  • Cell Source
  • Donor Type
  • CAR Construct (costimulatory domain, vector, etc)
  • Cell Dose(s)
  • Mode of Administration (route and # doses)
  • Conditioning
  • Drug Support/Combos
• Sponsor Data
  • Academia or Industry Funding
  • Sponsor Name
  • Study Acronym
• Additional Information
  • Product Name
  • Notes - includes secondary trial IDs and reasons for termination

A graph of CAR-Immunotherapy trial numbers and phase versus time shows the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. There were 115 new CAR-Immunotherapy trials registered worldwide during the first half of 2018, and 41% of them were not registered in ClinicalTrials.gov. Comparing them to the 152 trials in 2017, we see there is 51% increase in number of trials versus half of last year, and the number of late phase trials is on track to double.

Attachment	Size
Sample-CAR-immunotherapy-trials.xlsx	12.19 KB